Ye, Ji-Ming <br/><br/>
PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.  [electronic resource] 

 -  American journal of physiology. Endocrinology and metabolism  Mar 2003 
 - E531-40 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0193-1849 
<br/><br/><label>Standard No.: </label>10.1152/ajpendo.00299.2002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Dietary Fats--administration & dosage<br/>Fatty Liver--drug therapy<br/>Glucose--metabolism<br/>Glucose Clamp Technique<br/>Insulin--metabolism<br/>Insulin Resistance<br/>Lipid Metabolism<br/>Liver--metabolism<br/>Male<br/>Muscle, Skeletal--metabolism<br/>Oxazines--therapeutic use<br/>Phenylpropionates--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Rats<br/>Rats, Wistar<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Rosiglitazone<br/>Thiazoles--therapeutic use<br/>Thiazolidinediones<br/>Transcription Factors--agonists